Adaptive clinical trial design with delayed treatment effects using elicited prior distributions
James A. Salsbury, Jeremy E. Oakley, Steven A. Julious, Lisa V. Hampson · 2025
Read Adaptive clinical trial design with delayed treatment effects using elicited prior distributions by James A. Salsbury, Jeremy E. Oakley, Steven A. Julious, Lisa V. Hampson (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2509-07602.txt.
Description
James Salsbury's 2025 paper, with 3 co-authors, designs clinical trials that cope with treatments whose benefits arrive late. Trials with survival endpoints are central in cancer research, but immunotherapies often show delayed effects. Delay breaks the proportional hazards assumption behind standard tools like the Cox model and log-rank test, so an early interim look can wrongly suggest the treatment fails and kill the trial.
The framework builds prior distributions for the delayed effect by eliciting them from experts, then adapts the trial as data accumulate. Folding expert knowledge about timing and size of the delay into the design improves efficiency and robustness. The risk of premature termination falls, and real benefits that emerge over time stand a better chance of detection. An example illustrates how the elicited priors enter the design in practice.
Catalog record
| CREATOR | James A. Salsbury, Jeremy E. Oakley, Steven A. Julious, Lisa V. Hampson |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2509-07602